Clinical Trial Update: Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator. [Phase 2]

View source ↗

Summary

Phase 2 long-term safety study to assess safety of everolimus in patients already on treatment and benefiting from it.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2020-04-30